Skip to main content

Cancer Stem Cells in Metastasis Therapy

  • Chapter
  • First Online:
Cell Biology and Translational Medicine, Volume 2

Part of the book series: Advances in Experimental Medicine and Biology ((CBTMED,volume 1089))

Abstract

Tumors consists of subpopulation of cells in which each subtype has contributes to tumor progression. Specifically one subtype known as cancer stem cells are associated with the initiation, progression, resistance to conventional therapies and metastasis. Metastasis is leading cause of cancer related deaths. Overall it is important to consider cancer as a whole in which a mutated cell proliferating indefinitely and forming its hierarchy consisting of subgroups with different molecular signatures. To be able to target this disease we need to evaluate every step including initiation, progression, survival, angiogenesis and finally migration and repopulation. Cancer stem cells do play vital roles in each step however when metastasis can be stopped or eliminated we talk about saving a life or improving its quality. Considering how deeply these cancer stem like cells affect the tumor life and metastasis it is crucial to develop effective strategies against them. Metastatic cascade can also be directed by membrane derived vesicles specifically exosomes. Several studies show the role of exosomes in mediating cellular migration and pre-metastatic niche formation. During this chapter we wanted to explain in detail how the metastasis occur in tumor and how cancer stem cells contribute into the development of metastatic cascade and possibly suggest therapeutic approaches against cancer stem cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CSCs:

cancer stem cells

MMPs:

matrix metalloproteinases

EMT:

epithelial-to-mesenchymal transition

ALDH1A1:

Aldehyde Dehydrogenase 1 Family Member A1

RTKs:

receptor tyrosine kinases

MICs:

metastasis-initiating cells

TICs:

tumor-initiating cells

hWAPL:

human wings apart-like

HPV:

human papillomavirus

Pdcd4:

programmed cell death protein 4

CXCL12:

chemokine stromal cell-derived factor 1

VEGFR-1:

vascular endothelial growth factor receptor 1

CDs:

cluster of differentiation

CXCR4:

chemokine receptor complex 4

CAFs:

cancer associated fibroblasts

IGF-1:

insuling growth factor 1

IL-17A:

interleukin 17A

DTC:

disseminated tumor cell

MIF:

migration inhibitory factor

RARRES3:

Retinoic Acid Receptor Responder 3

NKX2-1:

homeobox domain-containing transcription

MITF:

microphthalmia-associated transcription factor

EVs:

Extracellular vesicles

ABs:

apoptotic bodies

References

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fikrettin Şahin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Aydemir Çoban, E., Şahin, F. (2018). Cancer Stem Cells in Metastasis Therapy. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 2. Advances in Experimental Medicine and Biology(), vol 1089. Springer, Cham. https://doi.org/10.1007/5584_2018_279

Download citation

Publish with us

Policies and ethics